In conclusion, our investigation found that NLRP3 inflammasome-related SNPs, especially NF-κB-94ins/del ATTG and CARD8 (rs2043211) genotype might serve as a novel biomarker and potential targets for ALL. This evidence concerns the gene NLRP3 and acute lymphoblastic leukemia.